NCT07666854Recruiting
Tele-Pulmonary Rehabilitation For COPD Patients Living in Peripheral Areas
Examining the Feasibility and Effectiveness of a Remote Group Respiratory Rehabilitation Program for Patients With Chronic Obstructive Pulmonary Disease Living in Peripheral Areas as a First Step to Policy Change
Source: ClinicalTrials.gov · Last updated 24 Sept 2026
Brief summary (registry, in English)
Pulmonary rehabilitation (PR) is a key non-pharmacological intervention for patients with chronic obstructive pulmonary disease (COPD), yet it remains underutilized, particularly among patients living in peripheral areas due to limited access, travel distance, and logistical barriers. Tele-pulmonary rehabilitation (TPR) has the potential to improve access to care, but its feasibility and effectiveness as a group-based intervention have not been well established. The aim of this study is to evaluate whether a group-based TPR program can improve treatment initiation and adherence compared to usual care, defined as referral to standard PR, among COPD patients living in peripheral areas. In addition, the study will assess the effect of the intervention on COPD exacerbations, symptom burden, quality of life, and patient satisfaction. This is a prospective randomized controlled trial that will enroll patients with COPD who are eligible for PR according to the Israeli health basket criteria and have not participated in PR in the past year. Participants will be randomly assigned to one of two groups: (1) referral to standard PR (control group), or (2) participation in a 12-week, twice-weekly, group-based TPR program delivered remotely via a dedicated application and video sessions (intervention group).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- First submitted
- 18 Jun 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 1 Jul 2028
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Diseases
- COPD
- NCT number
- NCT07666854
What you commit to
- Study type: Interventional
- Planned participants: 110
- From 1 Jul 2026 to the primary completion date, 1 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- An exacerbation in the 2-months prior to randomization.
Other illness
- Uncontrolled comorbidity (e.g uncontrolled congestive heart failure).
- Patients with cognitive impairment.
Other
- Inability to operate the mobile application.
- Without a mobile device or computer.
- Completed PR program in the last 12 months.
- Pregnancy.
Who the study is looking for
- Male and females Patients with COPD based on accepted criteria who are eligible for reimbursement of pulmonary rehabilitation (PR) according to the Israeli "health basket" criteria including one of the following:
- FEV1 below 50%
- Severe exacerbation (hospitalization) in the previous year
- Two moderate exacerbations in the previous year
- Willingness to initiate a PR or TPR programs.
- Living in geographic peripheral area.
- Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment.
- Agree to participate, with signed informed consent.
- Age \> 18.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tel-Aviv Sourasky Medical Center Coordinator of this site? Confirm its status | Tel Aviv | Israel | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.